RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 9, 2006, Pages 1073-1078

  Kelder, Wendy ^a,b   Van Den Berg, Anke ^a   Van Der Leij, Judith ^a   Bleeker, Wim ^c   Tiebosch, Anton T M G ^b   Grond, Joris K ^d   Baas, Peter C ^b   Plukker, John TH ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c Wilhelmina Ziekenhuis   (Netherlands)

^d Public Health Service of Northern Friesland   (Netherlands)

Author keywords

Blue dye; colon cancer; immunohistochemistry; lymph nodes; polymerase chain reaction; sentinel node

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COLORING AGENT; DIAGNOSTIC AGENT; DISULFINE BLUE; DNA; FUCHSINE; KERATIN;

AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLON TUMOR; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; COLORING AGENTS; DNA, NEOPLASM; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 39049174866     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600554469     Document Type: Article

References (43)

1. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 1995; 19: 184–90
2. Greene, FL, Page, DL, Fleming, ID, Fritz, Ab, Balch, CM, Haller, D.b, Morrow, M. American Joint Committee on Cancer: cancer staging handbook, TNM classification of malignant tumors. New York: Springer; 2002. p 129.
3. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003; 10: 213–8
4. Wittekind C., Meyer HJ, Bootz F. TNM Klassification maligner Tumoren. Springer Verlag, Berlin 2002
5. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW, Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994; 73: 563–9
6. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223–8
7. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456–66
8. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–50
9. Morton DL, Wen DR, Wong JH, Economous JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9
10. Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002; 38: 977–85
11. Bilchik AJ, Nora DT, Sobin LH, Turner RR, Trocha S, Krasne D, Morton DL. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol 2003; 21: 668–72
12. Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001; 182: 40–3
13. Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002; 9: 550–4
14. Saha S, Nora D, Wong JH, Weise D. Sentinel lymph node mapping in colorectal cancer: a review. Surg Clin North Am 2000; 80: 1811–9
15. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000; 7: 120–4
16. Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique: a multicenter trial. Ann Surg Oncol::S 2001; 8: 94S–8S
17. Saha S. Selective lymph node mapping in colorectal cancer: a prospective study for impact on staging, limitations and pitfalls. Cancer Treat Res 2002; 111: 109–16
18. Wiese DA, Saha S, Badin J, Ng PS, Gauthier J, Ahsan A, Yu L. Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med 2000; 124: 1759–63
19. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001; 233: 515–21
20. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W, Jr, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001; 8: 150–7
21. Broderick-Villa G, Ko A, O'Connell TX, Guenther JM, Danial T, DiFronzo LA. Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer?. Cancer J 2002; 8: 445–50
22. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001; 182: 707–12
23. Braat AE, Oosterhuis JW, Moll FC, de Vries JE. Successful sentinel node identification in colon carcinoma using Patent Blue V. Eur J Surg Oncol 2004; 30: 633–7
24. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging?. Pathol Oncol Res 1999; 5: 291–6
25. Evangelista W, Satolli MA, Malossi A, Mussa B, Sandrucci S. Sentinel lymph node mapping in colorectal cancer: a feasibility study. Tumori 2002; 88: 37–40
26. Gandy CP, Biddlestone LR, Roe AM, O'Leary DP. Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002; 4: 447–9
27. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999; 86: 482–6
28. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, Mccall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001; 44: 410–7
29. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001; 158: 419–29
30. Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004; 240: 624–8
31. Read TE, Fleshman JW, Caushaj PF. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis Colon Rectum 2005; 48: 80–5
32. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001; 19: 1128–36
33. Dorudi S, Kinrade E, Marshall NC, Feakins R, Williams NS, Bustin SA. Genetic detection of lymph node micrometastases in patients with colorectal cancer. Br J Surg 1998; 85: 98–100
34. Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998; 68: 34–40
35. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998; 16: 128–32
36. Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002; 20: 4232–41
37. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002; 20: 1049–55
38. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996; 162: 637–42
39. Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991; 34: 917–20
40. Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, et al. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res 2002; 8: 759–67
41. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001; 8: 300–4
42. Haboubi NY, Abdalla SA, Amini S, Clark P, Dougal M, Dube A, Schofield P. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis 1998; 13: 99–102
43. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999; 27: 4436–43